“The theme is ‘Boundless Horizons,’ which challenges our limits and makes us look forward to possibilities, reflecting the expanding use of Gamma Knife and the yet to be imagined potential of this form of surgery,” says Prof. Michael K. Morgan, M.D., Dean, at Sydney’s Macquarie University Hospital (MUH), which is hosting the event at the city’s Hilton Hotel. “The focus on cancer at the meeting reflects the importance of Gamma Knife in the treatment of this disease, however, the program comprehensively covers all aspects of innovation in Gamma Knife surgery for brain disorders.

MUH acquired the continent’s first Leksell Gamma Knife® Perfexion™, in 2010, and is the first and only center in Australia to provide dedicated intracranial radiosurgery. The technological capabilities of Gamma Knife are in high demand in Australia, as an estimated 1,400 new cases of malignant brain tumors – and many more benign tumors – are diagnosed annually. More than 1,200 Australians die each year from malignant and benign brain tumors.*

*”Statistics on Incidence, Survival Rates and Mortality Associated with Brain Tumours in Australia,” Information Paper for the Australian Brain Tumour Advocacy Group, Denise Chang, June 2003.